A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

NCT01436864 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL: Recombinant Human VEGF Receptor-Fc Fusion Protein

Sponsor

Chengdu Kanghong Biotech Co., Ltd.

Collaborators

[object Object]